SEC Form 4 · accession 0001649904-26-000020
RHYTHM PHARMACEUTICALS, INC. · RYTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Manher Joshi
Officer — Chief Medical Officer
Period of report
Aug 17, 2026
Accepted (ET)
Aug 18, 2026 · 5:35 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001649904
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $115.44 | Aug 17, 2026 | A | 50,000 | A | — | Aug 16, 2036 | Common Stock | 50,000 | 50,000 | D |
| Restricted Stock UnitsF2,F3 | $0.00 | Aug 17, 2026 | A | 25,000 | A | — | — | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The Stock Options vest and become exercisable as to 25% of the total number of shares subject to the option on the first anniversary of the grant date and as to 6.25% of the total number of shares subject to the option upon the Reporting Person's completion of each successive three months of service to the Corporation.
- F2The Restricted Stock Units vest as to 25% of the Restricted Stock Units on September 1 of each of 2027, 2028, 2029, and 2030, such that the Restricted Stock Units shall be fully vested on September 1, 2030, subject to the Reporting Person continuing in service through each such vesting date.
- F3The restricted stock units have no expiration date.